Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0010200 (
cough
)
23,843
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microarray studies have shown that matrilysin or matrix metalloproteinase (MMP)-7 is highly upregulated in the lungs of patients with idiopathic pulmonary fibrosis (IPF), but
MMP-7
protein expression has not been systematically compared between IPF and other interstitial lung diseases.
MMP-7
levels in bronchoalveolar lavage fluid (BALF) were compared to corresponding samples from nonspecific interstitial pneumonia (NSIP), sarcoidosis, and healthy controls.
MMP-7
levels in the BALF were determined by ELISA and localization of
MMP-7
in the lung tissue by immunohistochemistry.
MMP-7
was similarly elevated in the BALF of all these disorders compared to healthy controls (p=0.007). Even control subjects with prolonged
cough
displayed a tendency towards elevated
MMP-7
expression. There was a negative correlation between BALF
MMP-7
levels and forced expiratory vital capacity (r=-0.348, p=0.02, n=42). In IPF lung,
MMP-7
immunoreactivity appeared predominantly in the fibrotic parenchyma and arterial wall. In sarcoidosis and NSIP, prominent
MMP-7
immunoreactivity was found in areas of inflammation. These results demonstrate that elevated BALF
MMP-7
is not restricted to IPF alone but is also observed in other interstitial lung diseases and cannot be used as a differential diagnostic marker for IPF.
...
PMID:Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases. 1769 54